Roosevelt Investment Group’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-4,266
Closed -$272K 154
2019
Q1
$272K Sell
4,266
-777
-15% -$44.3K 0.03% 126
2018
Q4
$257K Sell
5,043
-159
-3% -$8.04K 0.03% 173
2018
Q3
$302K Sell
5,202
-45
-0.9% -$2.2K 0.03% 136
2018
Q2
$255K Sell
5,247
-366
-7% -$17.1K 0.02% 141
2018
Q1
$261K Sell
5,613
-4,854
-46% -$211K 0.02% 151
2017
Q4
$393K Sell
10,467
-324,228
-97% -$11.9M 0.04% 139
2017
Q3
$12.2M Sell
334,695
-21,561
-6% -$822K 1.12% 33
2017
Q2
$14M Sell
356,256
-19,605
-5% -$716K 1.29% 30
2017
Q1
$11.8M Sell
375,861
-64,662
-15% -$2.02M 1.07% 34
2016
Q4
$13.8M Buy
440,523
+354,033
+409% +$11.5M 1.22% 29
2016
Q3
$3.48M Buy
86,490
+9,861
+13% +$371K 0.27% 82
2016
Q2
$2.55M Sell
76,629
-361,362
-83% -$12.4M 0.2% 82
2016
Q1
$12.9M Sell
437,991
-457,293
-51% -$12.6M 1.15% 37
2015
Q4
$23.6M Sell
895,284
-427,392
-32% -$11.1M 1.55% 24
2015
Q3
$31.3M Buy
+1,322,676
New +$31.9M 2.03% 12

Other funds holding EW

Roosevelt Investment Group's EW Position: Q2 2019 in Review

Roosevelt Investment Group sold out of Edwards Lifesciences (EW) in Q2 2019, closing a stake of 4,266 shares — an estimated $272K sold.

Roosevelt Investment Group first reported a position in EW in Q3 2015 and held it in 15 quarters. The position peaked at $31.3M in Q3 2015. 921 funds tracked by Wall St. Rank hold EW as of Q2 2019.

  • Roosevelt Investment Group reported no remaining Edwards Lifesciences position as of Q2 2019 after selling out during the quarter.
  • Roosevelt Investment Group sold 4,266 Edwards Lifesciences shares in Q2 2019, an estimated $272K.
  • Roosevelt Investment Group first reported a position in Edwards Lifesciences in Q3 2015 and held it in 15 quarters.
  • Roosevelt Investment Group's Edwards Lifesciences position peaked at $31.3M in Q3 2015.
  • 921 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2019.

Based on Roosevelt Investment Group's 13F filing for Q2 2019, filed 8 Aug 2019.